Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein MAK16 homolog is an essential nucleolar RNA-binding protein required for ribosome assembly, particularly the maturation of 5.8S rRNA and large ribosomal subunit rRNA[1][2][3]. Its deficiency leads to cell cycle arrest and impaired ribosome production, especially demonstrated in yeast. In humans, altered MAK16 expression has biomarker potential in cancer and autoimmunity, but currently there is no evidence it serves as a therapeutic drug target[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein MAK16 homolog (MAK16).